← Open Payments lookup

STEVEN CESSNA: Open Payments

NPI 1346750916 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$397 in 20 payments from 10 companies in 2025. Trend: 2023 $523 · 2024 $251 · 2025 $397

Food & beverage: $397
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc3$70
E.R. Squibb & Sons, L.L.C.3$50
Neurocrine BioSciences, Inc.2$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$49
Indivior Inc.2$39
Otsuka America Pharmaceutical, Inc.2$39
Axsome Therapeutics, Inc.2$34
Lundbeck LLC1$27
Braeburn Inc.1$23
ABBVIE INC.1$18

Products named: INVEGA SUSTENNA, COBENFY, INGREZZA, CAPLYTA, REXULTI, SUBLOCADE, Auvelity, BRIXADI.

Industry payments across LA — which companies pay providers there.